Cargando…
Periodontal surgery using rhFGF‐2 with deproteinized bovine bone mineral or rhFGF‐2 alone: 2‐year follow‐up of a randomized controlled trial
AIM: To compare outcomes of rhFGF‐2 + DBBM therapy with rhFGF‐2 alone in the treatment of intrabony defects. This study provides 2‐year follow‐up results from the previous randomized controlled trial. MATERIALS AND METHODS: Defects were randomly allocated to receive rhFGF‐2 + DBBM (test) or rhFGF‐2...
Autores principales: | Aoki, Hideto, Bizenjima, Takahiro, Seshima, Fumi, Sato, Masahiro, Irokawa, Daisuke, Yoshikawa, Kouki, Yoshida, Wataru, Imamura, Kentaro, Matsugami, Daisuke, Kitamura, Yurie, Kita, Daichi, Sugito, Hiroki, Tomita, Sachiyo, Saito, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984167/ https://www.ncbi.nlm.nih.gov/pubmed/33030228 http://dx.doi.org/10.1111/jcpe.13385 |
Ejemplares similares
-
Treatment of intrabony periodontal defects using rhFGF‐2 in combination with deproteinized bovine bone mineral or rhFGF‐2 alone: A 6‐month randomized controlled trial
por: Saito, Atsushi, et al.
Publicado: (2019) -
Periodontal Regenerative Therapy Using rhFGF-2 and Deproteinized Bovine Bone Mineral versus rhFGF-2 Alone: 4-Year Extended Follow-Up of a Randomized Controlled Trial
por: Seshima, Fumi, et al.
Publicado: (2022) -
Efficient treatment of Parkinson’s disease using ultrasonography-guided rhFGF20 proteoliposomes
por: Niu, Jianlou, et al.
Publicado: (2018) -
Sprifermin (rhFGF18) modulates extracellular matrix turnover in cartilage explants ex vivo
por: Reker, Ditte, et al.
Publicado: (2017) -
Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/db and DIO mice
por: Zhao, Longwei, et al.
Publicado: (2017)